Most read article(s)

Open Access
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D₂ Receptor Mechanism of Action
Nina Dedic, Philip G. Jones, Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy and Kenneth S. Koblan

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 1-14; DOI: https://doi.org/10.1124/jpet.119.260281
Open Access
Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity
Jaromir Vlach, Andrew T. Bender, Melinda Przetak, Albertina Pereira, Aditee Deshpande, Theresa L. Johnson, Sonja Reissig, Evgeni Tzvetkov, Djordje Musil, Noune Tahmassian Morse, Philipp Haselmayer, Simone C. Zimmerli, Shinji L. Okitsu, Robert L. Walsky and Brian Sherer

Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 397-409; DOI: https://doi.org/10.1124/jpet.120.000275
Open Access
Characterizing Pharmacokinetic–Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L. McLeod, Malgorzata A. Gil, Dapeng Chen, Antonio Cabal, Jason Katz, Joey Methot, Janice D. Woodhouse, Lauren Dorosh, Prasanthi Geda, Khamir Mehta, Milenko Cicmil, Gretchen A. Baltus, Alan Bass, Hani Houshyar, Michael Caniga, Hongshi Yu, Francois Gervais, Stephen Alves and Sanjiv Shah

Journal of Pharmacology and Experimental Therapeutics May 2019, 369 (2) 223-233; DOI: https://doi.org/10.1124/jpet.118.252551
You have access
Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment
Anna Moszczynska and Sean Patrick Callan

Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 474-488; DOI: https://doi.org/10.1124/jpet.116.238501
You have access
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya and Thomas J. Abbruscato

Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 498-509; DOI: https://doi.org/10.1124/jpet.120.000170
Open Access
Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Zizhen Si and Xidi Wang

Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 207-217; DOI: https://doi.org/10.1124/jpet.120.000324
Open Access
Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile
Tjeerd Barf, Todd Covey, Raquel Izumi, Bas van de Kar, Michael Gulrajani, Bart van Lith, Maaike van Hoek, Edwin de Zwart, Diana Mittag, Dennis Demont, Saskia Verkaik, Fanny Krantz, Paul G. Pearson, Roger Ulrich and Allard Kaptein

Journal of Pharmacology and Experimental Therapeutics November 2017, 363 (2) 240-252; DOI: https://doi.org/10.1124/jpet.117.242909
You have access
Oxidative Stress and the Central Nervous System
Samina Salim

Journal of Pharmacology and Experimental Therapeutics January 2017, 360 (1) 201-205; DOI: https://doi.org/10.1124/jpet.116.237503
You have access
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino, Roberta Verde, Massimo Vaia, Marco Allarà, Teresa Iuvone and Vincenzo Di Marzo

Journal of Pharmacology and Experimental Therapeutics June 2018, 365 (3) 652-663; DOI: https://doi.org/10.1124/jpet.117.244368
Open Access
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data
Mikael Wallman, Stefan Scheuerer, Eric Martel, Nicolas Pairet, Mats Jirstrand and Johan Gabrielsson

Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 218-231; DOI: https://doi.org/10.1124/jpet.120.000348

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals